Loss of IL-6 and use of inhibitors of STAT3 and MEK/ERK pathways suppress tumorigenesis in 3D organotypic and tumoroid models, showing how STAT3 and MEK/ERK pathways are also solicited in crosstalk between tumour cells and GCAFs for the maintenance of tumour integrity [76]. The gene discussed is STAT3; the disease is neoplasm.